Dental erosion caused by glucocorticoid therapy in a patient with optic neuritis: a case report / 华西口腔医学杂志

Dental erosion is characterized by progressively destroyed teeth, which has no relation to bacteria but to chemicals. Some internal factors, such as gastroesophageal reflux induced by bulimia, anorexia, gastrointestinal diseases, or drugs, and external factors, such as diet, drugs, and occupational acid exposure, are considered promotive factors for this disease. This article presents a patient suffering from severe dental erosion in the whole dentition, especially in the maxillary teeth, due to gastroesophageal reflux induced by glucocorticoid therapy for optic neuritis. This article discusses the mechanism between optic neuritis glucocorticoid therapy and dental erosion.

Análisis de causas atribuidas a "BRUE" entre los años 2017 a 2020 / Analysis of etiologies attributed to "BRUE" between the years 2017 to 2020

El término BRUE describe un evento en un lactante menor, repentino, breve, ya resuelto y sólo aplica cuando no existe una explicación para este episodio. Es escasa la literatura nacional e internacional sobre el estudio etiológico en BRUE. Objetivos: Caracterizar lactantes con episodio de BRUE y hacer un análisis etiológico. Métodos: Estudio retrospectivo, descriptivo lactantes hospitalizados por BRUE. Resultados: Se encontraron 50 lactantes con BRUE, la mayoría de ellos presentó un solo evento y ninguno requirió reanimación cardiopulmonar. Las características principales de los eventos fueron apnea, cianosis y tono disminuido. Las etiologías encontradas, más habituales, fueron reflujo gastro-esofágico, infección respiratoria, mala técnica alimentaria y crisis epilépticas. La evaluación clínica fue el principal elemento diagnóstico. Discusión: Nuestro análisis etiológico concuerda con la literatura nacional e internacional. La anamnesis y examen físico son la principal herramienta diagnóstica. Es fundamental contar con guías, adaptadas a la realidad nacional y local, que dirijan el estudio de lactantes con BRUE.

BRUE is an event occurring in an infant when the observer reports a sudden, brief, and now-resolved episode. BRUE is a diagnosis of exclusion and is used only when there is no explanation for the event after conducting an appropriate history and physical examination. There is little literature on the etiological study in BRUE. Objectives: To characterize infants with a BRUE episode and to carry out an etiological analysis. Methods: A retrospective study including infants who have experienced a BRUE between the years 2017 to 2020. Results: 50 infants with BRUE, most of them presented a single event and none required cardiopulmonary resuscitation. The main characteristics of the events were apnea, cyanosis and decreased tone. The most common etiologies found were gastroesophageal reflux, respiratory infection, poor feeding technique, and seizures. History and physical examination are the fundamental diagnostic tools. Discussion: Our etiological analysis agrees with the national and international literature. The clinical evaluation was the main diagnostic tool. It is essential to create local guidelines for the evaluation investigation and management of infants with BRUE.

Pacientes con diagnóstico de "BRUE" atendidos en hospital pediátrico chileno. Aplicando nueva terminología / Patients with diagnosis of "Sids" treated in chilean pediatric hospital. Applying new terminology

La posible relación entre apneas durante la infancia temprana y Síndrome de Muerte Súbita del Lactante (SMSL) nunca ha sido demostrada, existiendo evidencias de que ambas condiciones podrían no estar relacionadas. La Academia Americana de Pediatría (AAP) define ALTE (Acute Life Threatening Event), como un evento brusco e inesperado que incluye manifestaciones de apnea junto con cambios de coloración cutánea y de tono muscular, donde el observador cree que el niño ha muerto. La AAP ha propuesto recientemente la sustitución del término ALTE por Brief Resolved Unexplained Events (BRUE). El nuevo concepto permite categorizar eventos breves, resueltos e inexplicados, para optimizar mejor el recurso en salud, a través de objetivar el evento y entregando estrategias de manejo categorizando el riesgo. Objetivo: Describir las características clínicas y letalidad de los pacientes menores de 12 meses que consultan por BRUE en un hospital de referencia. Materiales y métodos: Estudio transversal descriptivo con revisión de ficha de 46 pacientes de la Unidad de Lactantes y Nutrición del Hospital Dr. Luis Calvo Mackenna, con diagnóstico de BRUE, entre enero a diciembre de 2017. Resultados: Del total de pacientes con BRUE, 45% fueron hombres y 55% mujeres. La edad promedio fue de 1,37 + 0,51 meses. En 70% se demostró una etiología, de estas 31% con enfermedad por reflujo gastroesofágico (ERGE), siendo ésta la causa más frecuente seguida de un 19% con infecciones respiratorias agudas (IRA) y 9% causas neurológicas. En el 30% fueron causas idiopáticas. Conclusión: En nuestro estudio las causas más frecuentes de BRUE fueron ERGE e infecciones respiratorias. Durante el período de estudio ningún paciente estudiado falleció, por lo que no encontramos relación entre apneas del lactante y síndrome de muerte súbita.

The possible relationship between apneas during early childhood and Sudden Infant Death Syndrome (SIDS) has never been demonstrated, and there is evidence that the two conditions may not be related. The American Academy of Pediatrics (AAP) defines ALTE (Acute Life Threatening Event), as an abrupt and unexpected event that includes manifestations of apnea along with changes in skin color and muscle tone, where the observer believes that the child has died. The AAP has recently proposed replacing the term ALTE with Brief Resolved Unexplained Events (BRUE). The new concept makes it possible to categorize brief, resolved and unexplained events, to better optimize the health resource, through objectifying the event and delivering management strategies by categorizing the risk. Objective: To describe the clinical characteristics and lethality of patients younger than 12 months who consult for BRUE in a referral hospital. Materials and methods: Descriptive cross-sectional study with revision of the file of 46 patients from the Infant and Nutrition Unit of the Dr. Luis Calvo Mackenna Hospital, with a diagnosis of BRUE, between January and December 2017. Results: Of the total number of patients with BRUE, 45% were men and 55% women. The average age was 1.37 + 0.51 months. An etiology was demonstrated in 70%, of these 31% with gastroesophageal reflux disease (GERD), this being the most frequent cause, followed by 19% with acute respiratory infections (ARI) and 9% with neurological causes. In 30% they were idiopathic causes. Conclusion: In our study, the most frequent causes of BRUE were GERD and respiratory infections. During the study period, no patient studied died, so we found no relationship between apnea in the infant and sudden death syndrome.

Distúrbios funcionais esofágicos na avaliação pré-operatória de cirurgia bariátrica / Esophageal functional disorders in the pre-operatory evaluation of bariatric surgery

ABSTRACT BACKGROUND: Obesity is an independent risk factor for esophageal symptoms, gastroesophageal reflux disease (GERD), and motor abnormalities. When contemplating bariatric surgery, patients with obesity type III undergo esophagogastroduodenoscopy (EGD) and also esophageal manometry (EMN), and prolonged pHmetry (PHM) as part of their pre-operative evaluation. OBJECTIVE: Description of endoscopy, manometry and pHmetry findings in patients with obesity type III preparing for bariatric surgery, and correlation of these findings with the presence of typical GERD symptoms. METHODS: Retrospective study in which clinical symptoms of GERD were assessed, focusing on the presence of heartburn and regurgitation. All patients underwent EMN, PHM and most of them EGD. RESULTS: 114 patients (93 females-81%), average age 36 years old, average BMI of 45.3, were studied. Typical GERD symptoms were referred by 43 (38%) patients while 71 (62%) were asymptomatic. Eighty two patients (72% of total) underwent EGD and 36 (42%) evidenced esophageal abnormalities. Among the abnormal findings, hiatal hernia was seen in 36%, erosive esophagitis (EE) in 36%, and HH+EE in 28%. An abnormal EMN was recorded in 51/114 patients (45%). The main abnormality was a hypotensive lower esophageal sphincter (LES) in 32%, followed by ineffective esophageal motility in 25%, nutcracker esophagus in 19%, IEM + hypotensive LES in 10%, intra-thoracic LES (6%), hypertensive LES (4%), aperistalsis (2%) and achalasia (2%). Among the 43 symptomatic patients, 23 (53%) had abnormal EMN and 31/71 asymptomatic cases (44%) also presented this finding (P=0.30). PHM showed abnormal reflux in 60/114 patients (53%), with a predominance of bi-positional reflux (42%), followed by supine reflux (33%) and upright reflux (25%). Abnormal PHM was found in 26/43 symptomatic cases (60%) and also among 34/71 asymptomatic cases (48%) (P=0.19). CONCLUSION: Manometric abnormalities were common in obesity type III patients, the most frequent being hypotensive LES, followed by IEM. Most patients were asymptomatic. There was no correlation between the finding of motor abnormalities and the presence of symptoms. More than half the patients had abnormal reflux at PHM. We found no significant correlation between abnormal reflux and the presence of symptoms.

RESUMO CONTEXTO: A obesidade é fator de risco independente para sintomas esofagianos, doença do refluxo gastroesofágico (DRGE) e alterações motoras. Pacientes com obesidade tipo III, candidatos à cirurgia bariátrica foram submetidos a endoscopia digestiva alta (EDA) e também realizaram esofagomanometria (EMN) e pHmetria prolongada (PHM) como parte da avaliação pré-operatória. OBJETIVO: Em um grupo de pacientes com obesidade tipo III em pré-operatório de cirurgia bariátrica, descrever os achados endoscópicos, manométricos e pHmétricos, correlacionando-os com a presença de sintomas típicos de DRGE. MÉTODOS: Estudo retrospectivo, de pacientes com obesidade tipo III, candidatos a cirurgia bariátrica. A avaliação clínica focalizou a presença de sintomas típicos de DRGE (pirose/regurgitação); todos foram submetidos a EMN, PHM e a maior parte à EDA, realizada previamente. RESULTADOS: Foram incluídos 114 pacientes, 93 (81%) do sexo feminino, média de idade de 36 anos e IMC médio de 45,3. Sintomas típicos de refluxo foram referidos por 43 (38%) pacientes e 71 (62%) eram assintomáticos. EDA foi realizada por 82 (72%) pacientes, havendo anormalidades esofagianas em 36 (42%). Entre os anormais, havia hérnia hiatal (HH) em 36%, esofagite erosiva (EE) em 36% e HH + EE em 28%. A EMN foi anormal em 51/114 (45%). Entre os anormais, predominou o esfíncter esofagiano inferior (EEI) hipotenso em 32%, seguido por motilidade esofagiana ineficaz (MEI) em 25%, esôfago em quebra-nozes (19%), EEI hipotenso + MEI (10%), EEI intra-torácico (6%), EEI hipertenso (4%), aperistalse (2%) e acalasia (2%). Dentre os 43 sintomáticos, 23 (53%) apresentavam EMN anormal, sendo que em 31 dos 71 (44%) assintomáticos a EMN também era anormal (P=0,30). A PHM revelou refluxo anormal em 60 (53%) pacientes. Predominou o refluxo anormal biposicional (42%) seguido do refluxo supino (33%) e refluxo ereto (25%). Dentre os 43 pacientes sintomáticos, 26 (60%) apresentavam PHM anormal, sendo que em 34 dos 71 assintomáticos a PHM também era anormal (48%) - P=0,19. CONCLUSÃO: Alterações manométricas foram comuns em obesidade tipo III, sendo as mais frequentes o EEI hipotenso, seguida de motilidade ineficaz. A maioria dos pacientes era assintomática. Mais da metade dos pacientes apresentou refluxo anormal à PHM. Não houve diferença significativa entre o achado de refluxo anormal e a presença de sintomas. Não houve relação entre o achado de alterações motoras e a presença de sintomas.

Páncreas ectópico en antro gástrico asociado a síntomas de reflujo. Reporte de un caso / Ectopic pancreas in gastric antrum associated to reflux symptoms. Report of a case

RESUMEN El páncreas ectópico es una entidad poco común. Como tumor submucoso de origen congénito, frecuentemente presenta un curso asintomático, aunque con posibles complicaciones. Su diagnóstico de certeza se basa en la endoscopia, el ultrasonido endoscópico y la histología, que permiten adoptar una conducta expectante o quirúrgica. El paciente estudiado presentó un páncreas ectópico localizado en antro gástrico asociado a síntomas de reflujo gastroesofágico rebeldes a tratamiento, los cuales motivaron el estudio endoscópico, con el consecuente hallazgo de dicha entidad (AU).

ABSTRACT Ectopic pancreas is a little common entity. As congenital-originated sub mucous tumor, it frequently presents an asymptomatic course, though with possible complications. Its definitive diagnosis is based in the endoscopy, endoscopic ultrasound and histology, allowing to adopt an expectant or surgical behavior. The current patient presented an unresponsive-to-treatment ectopic pancreas located in the gastric antrum associated to gastro-esophageal reflux symptoms. This motivated the endoscopic study consequently leading to finding this entity (AU).

Alternativas de tratamiento para pacientes jóvenes con pérdida de estructura dentaria. Parte 1: caso clínico / Treatment alternatives for young patients with loss of dental structure. Part 1: a clinical Case

El objetivo de este artículo es presentar una alternativa de tratamiento rehabilitador para pacientes jóvenes con gran pérdida de estructura dental vinculada a lesiones de origen no bacteriano. Se presenta el caso clínico de un paciente de 36 años de edad, con reflujo gastroesofágico crónico bajo tratamiento médico, que concurrió a la Cátedra de Odontología Integral Adultos de la Facultad de Odontología de la Universidad de Buenos Aires (FOUBA), en busca de un cambio estético en su sonrisa y relatando sensibilidad al calor, al frío y dolor al masticar. No manifestó sintomatología dolorosa a nivel muscular ni articular. En función de sus posibilidades económicas y de la etiología erosiva de las lesiones existentes en sus piezas dentarias, se llevó a cabo una rehabilitación oral adhesiva con resinas compuestas utilizando la sistematización de atención que sugiere la Cátedra. Las resinas compuestas actuales, en combinación con las técnicas y procedimientos desarrollados en este artículo han demostrado un adecuado comportamiento al ser utilizadas como restauraciones definitivas en pacientes que necesitan rehabilitación oral total debido a la gran pérdida de estructura dental por erosión ácida (AU)

Lesiones dentales asociadas a enfermedad por reflujo gastroesofágico en pediatría / Dental Injuries Associated with Gastroesophageal Reflux Disease in Pediatrics

Acta Pediátrica Hondureña, Vol. 11 No.2/ Octubre 2020 a Marzo 2021 1186 El reflujo gastroesofágico (RGE) es el paso fisio- lógico del contenido gástrico hacia el esófago, presente en condiciones normales a cualquier edad y es uno de los problemas gastrointestinales más comunes en niños. El estado nutricional es adecuado y muchas veces por arriba de los per- centiles de peso y talla y es un niño "vomitador feliz". En cambio, la enfermedad por reflujo gas- troesofágico (ERGE) está asociada con síntomas molestos respiratorios, digestivos, trastornos durante el sueño, lesiones dentales las que en un gran número de casos pasan desapercibidas y son notadas hasta que han causado un daño signifi- cativo y pueden ir desde prurito, ardor de muco- sa, aumento de la sensibilidad dental y lingual, sabor amargo, erosiones hasta caries dental, estas cumplen un importante papel en la edad pediá- trica, sobre todo cuando el niño presenta trastor- nos en las funciones neurosensoriales, motoras, como daño neurológico secundario a encefalo- patía hipóxico isquémica, defectos del tubo neu- ral, atresia esofágica y enfermedades degene- rativas. Dentro de las complicaciones de ERGE cabe resaltar neumonía por broncoaspiración, otitis, faringoamigdalitis, crup y compromiso en el estado nutricional. La ERGE tiene gran impor- tancia médica y social debido al incremento en su incidencia y a los síntomas duraderos ya que reducen la calidad de vida. La habilidad de poder distinguir entre las mani- festaciones clínicas de RGE y ERGE en los dife- rentes grupos etarios nos permite identificar que pacientes deben ser extensamente evaluados y manejados con tratamiento conservador o si es- tos requieren ser derivados al odontólogo pedia- tra. Debido a que existe desconocimiento acerca de las lesiones dentales que se producen en la ERGE decidimos hacer la presente revisión ya que es muy importante que el personal de salud: estudiantes, médicos y odontólogos sean capaces de identificar, diagnosticar e implementar reco- mendaciones apropiadas, dar tratamiento espe- cífico tanto desde el punto de vista médico como dental dadas las repercusiones que esta conlleva y así derivar oportunamente...(AU)

Esôfago de Barrett: o estado da arte / Barrett's Esophagus: the state of the art

Objetivo: Demonstrar fatores envolvidos nos distúrbios do sono em profissionais que fazem plantões. Métodos: Trata-se de estudo transversal, cuja amostra foi composta de 244 voluntários, plantonistas da área da saúde, sendo 191 do sexo feminino, que responderam a um questionário socioeconômico, associado à aplicação da Escala de Sonolência de Epworth e ao Índice de Qualidade do Sono de Pittsburgh. Os dados foram analisados pelos coeficientes de Spearman e de Kendall Tau, com distribuição de probabilidade gama. Resultados: Houve significância (p<0,05) com o Índice de Qualidade do Sono de Pittsburgh e a atividade física (+0,216), ergonomia (+0,148), filhos (-0,146), valor da remuneração (+0,112) e disfunção durante o dia (+0,352). Também houve significância com a Escala de Sonolência de Epworth e atividade física (+0,138), renda familiar (-0,118), trabalho semanal (-0,151), latência do sono (-0,106), duração do sono (-0,107), eficiência do sono (-0,139) e disfunção durante o dia (+0,170). Por fim, a eficiência do sono teve significiância com profissão (-0,209), tabagismo (+0,402), Escala de Sonolência de Epworth (-0,139) e dissonias com a obesidade (índice de massa corporal >30; razão de chance de 1,40; intervalo de confiança de 95% de 1,02-1,94). Conclusão: As medidas autorrelatadas são prontamente obtidas com questionários validados, como a Escala de Sonolência de Epworth e o Índice de Qualidade do Sono de Pittsburgh, encontrando-se correlações com renda familiar, ter ou não filhos, índice de massa corporal, atividade física, ergonomia, condições de trabalho, tabagismo e componentes biopsicossociais. Em virtude do caráter transversal deste estudo é indispensável mais estudos com maior follow-up

Objective: To demonstrate factors involved in sleep disorders in professionals who take shifts. Methods: This is a cross-sectional study whose sample consists of 244 volunteers, on-duty health workers, 191 females, who answered a socioeconomic questionnaire, associated with application of the Epworth Sleepiness Scale and the Pittsburgh Sleep Quality Index. Data were analyzed with Spearman's and Kendall Tau coefficients, and gamma probability distribution. Results: There was significance (p<0,05) with the Pittsburgh Sleep Quality Index and physical activity (+0,216), ergonomics (+0,148), children (-0,146), the wage (+0,112), dysfunction during the day (+0,352). Also there was significance with the Epworth Sleepiness Scale and physical activity (+0,138), family income (-0,118), weekly workload (-0,151), sleep latency (-0,106), sleep duration (-0,107), sleep efficiency (-0,139), and dysfunction during the day (+0,170). Finally, sleep efficiency was significant with occupation (-0,209), smoking habits (+0,402), Epworth Sleepiness Scale (-0,139), dyssomnia with obesity (body index mass >30; OR of 1,40; CI 95% 1,02-1,94). Conclusion: Self-reported measures are readily obtained with validated questionnaires such as Epworth Sleepiness Scale and Pittsburgh Sleep Quality Index, with correlations with family income, having children or not, body mass index, physical activity, ergonomics, working conditions, smoking habits, and biopsychosocial components. Due to the cross-sectional nature of this study, further research with longer follow-up is indispensable

Etiologia e fatores associados à halitose: uma revisão integrativa da literatura / Etiology and factors associated with halitosis: an integrative literature review

Objetivo: avaliar quais as possíveis causas e quais são os fatores associados ao surgimento da halitose. Métodos: foi realizada uma revisão nos bancos de dados PubMed e SciELO, utilizando os descritores e sinônimos MeSH organizados em lógica booleana: 'Halitosis' AND 'Risk Factors' OR 'Association' OR 'Etiologies', com as seguintes etapas: identificação dos artigos, triagem, elegibilidade e inclusão. Apenas artigos publicados entre os anos de 2015-2020, ensaios clínicos randomizados, estudos transversais ou de coorte foram incluídos na revisão. Foram excluídos protocolos de estudos e os artigos que não estavam nos critérios e objetivo desta revisão. Resultados: de 240 artigos encontrados, 22 foram inclusos. Desses, 50% demonstraram que a falta ou a deficiência dos hábitos de higiene oral se relacionam com a halitose. Ainda, 40,9% deles se referem à saburra lingual como um forte fator etiológico e 36,4% demonstram que a doença periodontal está diretamente associada com o mau hálito. Além disso, em relação a outras condições locais e sistêmicas, xerostomia (13,6%), doença gastrointestinal e refluxo laringofaríngeo (9,1%), rinite e diabetes (4,5%) também demonstraram associação. Considerações finais: a halitose pode estar associada com higiene bucal, saburra lingual, doença periodontal, alguns hábitos e quadros sistêmicos.(AU)

Objective: to evaluate the possible causes and what are the factors associated with the onset of halitosis. Methods: a review was performed in the PubMed and SciELO databases, using the descriptors and synonyms MeSH organized in Boolean logic: 'Halitosis' AND 'Risk Factors' OR 'Association' OR 'Etiologies', with the following steps: identification of articles, screening, eligibility and inclusion. Only articles published between 2015- 2020; randomized clinical trials; cross-sectional or cohort studies were included in the review. Study protocols and articles that were not in the criteria and objective of this review were excluded. Results: Of 240 articles found, 22 were included. Of those, 50% showed that the lack or deficiency of oral hygiene habits are related to halitosis. Furthermore, 40.9% of them refer to tongue coating as a strong etiological factor and 36.4% demonstrate that periodontal disease is directly associated with bad breath. Moreover, in relation to other local and systemic conditions, xerostomia (13.6%), gastrointestinal disease and laryngeal reflux (9.1%), rhinitis and diabetes (4.5%) also demonstrated an association. Final considerations: Halitosis may be associated with oral hygiene, lingualcoating, periodontal disease, some habits and systemic conditions.(AU)

Real-world evidence of health outcomes and medication use 24 months after bariatric surgery in the public healthcare system in Brazil: a retrospective, single-center study

OBJECTIVES: The number of bariatric procedures has significantly increased in Brazil, especially in the public Unified Health System. The present study describes health outcomes and medication use in obese patients treated in a major hospital that performs publicly funded surgery in Brazil. METHODS: A retrospective, single center study was conducted to collect real-world evidence of health outcomes and medication use in 247 obese patients (female, 82.2%) who underwent open Roux-en-Y gastric bypass. Changes in weight and body mass index (BMI), presence of apnea, hypertension, and type 2 diabetes (T2D), and medication use (hypertension, diabetes, and dyslipidemia) were assessed preoperatively and up to 24 months postoperatively. The mean cost of medications was calculated for the 12-month preoperative and 24-month postoperative periods. RESULTS: During the surgery, the mean age of patients was 43.42 years (standard deviation [SD], 10.9 years), and mean BMI was 46.7 kg/m2 (SD, 6.7 kg/m2). At 24 months, significant declines were noted in weight (mean, -37.6 kg), BMI (mean, -14.3 kg/m2); presence of T2D, hypertension, and apnea (-29.6%, -50.6%, and -20.9%, respectively); and number of patients using medications (-66.67% for diabetes, -41.86% for hypertension, and -55.26% for dyslipidemia). The mean cost of medications (total costs for all medications) decreased by >50% in 12-24 postoperative months compared to that in 12 preoperative months. CONCLUSION: Roux-en-Y gastric bypass successfully reduced weight, BMI, and comorbidities and medication use and cost at 24 months in Brazilian patients treated in the public Unified Health System.

Algunas consideraciones sobre el reflujo gastroesofágico en infantes / Several view about gastroesophageal reflux in children

RESUMEN El reflujo gastroesofágico presenta variaciones en cuanto a su definición, pero continúa causando una elevada morbilidad y mortalidad, a pesar que las estadísticas no recogen cifras exactas, su manejo sigue siendo controversial. En la práctica médica, se podría decir que el reflujo gastroesofágico fisiológico, no patológico, usualmente se acompaña de regurgitación, y que en esta enfermedad el síntoma principal de presentación en los niños, es el vómito. Cuando el reflujo gastroesofágico es mantenido, persistente, a pesar de la medidas posturales y dietéticas indicadas, provocando sintomatología digestiva y extradigestiva, se considera patológico, capaz de provocar una enfermedad por reflujo gastroesofágico. En neumología, no todo niño que tiene sibilancias es un asmático, en gastroenterología no todo niño que vomita o regurgita tiene un reflujo gastroesofágico. Actualmente, se conocen ciertas patologías y condiciones de tórpida evolución que por su historia natural y morbimortalidad, se catalogan como reflujo gastroesofágico refractario, cuyo pronóstico implica una diferente orientación terapéutica. El niño con reflujo gastroesofágico incluye las medidas antirreflujo, tratamiento medicamentoso y quirúrgico (AU).

ABSTRACT The Gastroesophageal Reflux presents variations as for its definition, but it continues causing a high morbility and mortality, to weigh that the statistics don't pick up exact report, its handling continues being controversial. In the medical practice, one could say that the reflux physiologic gastroesophageal, not pathological, usually accompanies of regurgitation, and that in this illness the main symptom of presentation in the children, is the vomit. When RGE is maintained, persistent, in spite of the measures posturales and dietary suitable, provoking digestive symptoms and extradigestive, it is considered pathological, able to provoke an illness for reflux gastroesophageal . In Neumology, not all boy that has lung sonority is an asthmatic one, in Gastroenterology not all boy that vomits or it regurgitation he has a reflux gastroesophageal. At the moment, certain pathologies and conditions of torpid evolution are known that for their natural history and morbimortality, they are classified as reflux refractory gastroesophageal whose presage implies a therapeutic different orientation. The boy with reflux gastroesophageal includes the measures antirreflux, treatment prescribes and surgical (AU).

Relación del reflujo gastroesofágico y manifestaciones respiratorias, desde el punto de vista de la gastroenterología pediátrica / Relationship between gastroesophageal reflux and respiratory manifestations, from the pediatric gastroenterologist point of view

Gastroesophageal reflux is a frequent condition in the daily life of infants and older children. When reflux causes symptoms, it is called gastroesophageal reflux disease. Different extraesophageal symptoms have been frequently attributed to gastroesophageal reflux, however, new diagnostic techniques available, such as pHmetry with impedance measurement, have allowed us to evaluate and eventually dismiss such relationships. In this article we review the relationship between gastroesophageal reflux and laryngeal pathology, chronic cough, asthma and aspiration. In general terms, the empirical treatment of a presumed reflux is not recommended in asymptomatic patients, in whom its presence is not demonstrated by techniques such as pHmetry with impedance, given that therapeutic response is low and similar to placebo, with potential adverse effects.

El reflujo gastroesofágico es una condición frecuente en la vida diaria de lactantes y niños mayores. Cuando produce síntomas, se denomina enfermedad por reflujo gastroesofágico. Se ha atribuido frecuentemente diferentes síntomas extraesofágicos al reflujo, sin embargo, nuevas técnicas diagnósticas disponibles, como la pHmetría con medición de impedanciometría, han permitido evaluar y eventualmente descartar tales asociaciones. En este artículo se revisa la relación entre el reflujo gastroesofágico y patología laríngea, tos crónica, asma y aspiración. En términos generales, no se recomienda el tratamiento empírico de un supuesto reflujo en pacientes asintomáticos, en quienes tampoco esté demostrada su presencia por técnicas como la pHmetría con impedanciometría, dado que la respuesta terapéutica es baja y similar a placebo, con potenciales efectos adversos.

Sintomas persistentes ao tratamento com inibidor da bomba de prótons são devidos à doença do refluxo gastroesofágico refratária ou decorrentes de outras afecções? / Are the persistent symptoms to proton pump inhibitor therapy due to refractory gastroesophageal reflux disease or to other disorders?

ABSTRACT BACKGROUND: Gastroesophageal reflux disease (GERD) is a clinical condition that develops when the reflux of stomach contents causes troublesome symptoms and/or complications. Transient lower esophageal sphincter relaxation is the main pathophysiological mechanism of GERD. Symptoms and complications can be related to the reflux of gastric contents into the esophagus, oral cavity, larynx and/or the lung. Symptoms and other possible manifestations of GERD are heartburn, regurgitation, dysphagia, non-cardiac chest pain, chronic cough, chronic laryngitis, asthma and dental erosions. The proton pump inhibitor (PPI) is the first-choice drug and the most commonly medication used for the treatment of GERD. The most widespread definition of Refractory GERD is the clinical condition that presents symptoms with partial or absent response to twice-daily PPI therapy. Persistence of symptoms occurs in 25% to 42% of patients who use PPI once-daily and in 10% to 20% who use PPI twice-daily. OBJECTIVE: The objective is to describe a review of the current literature, highlighting the causes, diagnostic aspects and therapeutic approach of the cases with suspected reflux symptoms and unresponsive to PPI. CONCLUSION: Initially, the management of PPI refractoriness consists in correcting low adherence to PPI therapy, adjusting the PPI dosage and emphasizing the recommendations on lifestyle modification change, avoiding food and activities that trigger symptoms. PPI decreases the number of episodes of acid reflux; however, the number of "non-acid" reflux increases and the patient continues to have reflux despite PPI. In this way, it is possible to greatly reduce greatly the occurrence of symptoms, especially those dependent on the acidity of the refluxed material. Response to PPI therapy can be evaluated through clinical, endoscopic, and reflux monitoring parameters. In the persistence of the symptoms and/or complications, other causes of Refractory GERD should be suspected. Then, diagnostic investigation must be initiated, which is supported by clinical parameters and complementary exams such as upper digestive endoscopy, esophageal manometry and ambulatory reflux monitoring (esophageal pH monitoring or esophageal impedance-pH monitoring). Causes of refractoriness to PPI therapy may be due to the true Refractory GERD, or even to other non-reflux diseases, which can generate symptoms similar to GERD. There are several causes contributing to PPI refractoriness, such as inappropriate use of the drug (lack of patient adherence to PPI therapy, inadequate dosage of PPI), residual acid reflux due to inadequate acid suppression, nocturnal acid escape, "non-acid" reflux, rapid metabolism of PPI, slow gastric emptying, and misdiagnosis of GERD. This is a common cause of failure of the clinical treatment and, in this case, the problem is not the treatment but the diagnosis. Causes of misdiagnosis of GERD are functional heartburn, achalasia, megaesophagus, eosinophilic esophagitis, other types of esophagitis, and other causes. The diagnosis and treatment are specific to each of these causes of refractoriness to clinical therapy with PPI.

RESUMO CONTEXTO: A doença do refluxo gastroesofágico (DRGE) é a condição clínica que se desenvolve quando o refluxo do conteúdo gástrico provoca sintomas incômodos e/ou complicações. O relaxamento transitório do esfíncter inferior do esôfago é o principal mecanismo fisiopatológico da DRGE. Os sintomas e complicações podem estar relacionados ao refluxo do conteúdo gástrico para o esôfago, cavidade oral, laringe e/ou pulmão. Os sintomas e outras possíveis manifestações da DRGE são pirose, regurgitação, disfagia, dor torácica não-cardíaca, tosse crônica, laringite crônica, asma e erosões dentárias. O inibidor da bomba de prótons (IBP) é o medicamento de primeira escolha e o mais comumente utilizado para o tratamento da DRGE. A definição mais difundida de DRGE Refratária é a condição clínica que apresenta sintomas com resposta parcial ou ausente ao tratamento com IBP duas vezes ao dia. A persistência dos sintomas ocorre em 25% a 42% dos pacientes que utilizam IBP uma vez ao dia e em 10% a 20% dos que utilizam IBP duas vezes ao dia. OBJETIVO: O objetivo é apresentar uma revisão da literatura atual, salientando as causas, aspectos diagnósticos e abordagem terapêutica dos casos com sintomas suspeitos de refluxo e não responsivos ao IBP. CONCLUSÃO - Inicialmente, o manejo da refratariedade ao IBP consiste em corrigir a baixa aderência à terapia com IBP, ajustar a dosagem do IBP e reforçar as recomendações sobre modificação do estilo de vida, evitando alimentos e atividades que desencadeiem os sintomas. O IBP diminui o número de episódios de refluxo ácido, no entanto o número de refluxos "não-ácidos" aumenta e o paciente continua apresentando refluxo apesar do IBP. Desta forma, é possível reduzir consideravelmente a ocorrência de sintomas, especialmente aqueles dependentes da acidez do material refluído. A resposta à terapia com IBP pode ser avaliada através de parâmetros clínicos, endoscópicos e de monitorização do refluxo. Na persistência dos sintomas, outras causas de DRGE Refratária devem ser suspeitadas. Em seguida, deve ser iniciada a investigação diagnóstica, que é apoiada por parâmetros clínicos e exames complementares, como endoscopia digestiva alta, manometria esofágica e monitorização ambulatorial do refluxo (pHmetria esofágica ou impedancio-pHmetria esofágica). As causas de refratariedade à terapia com IBP podem ser devidas à DRGE Refratária verdadeira ou mesmo a outras doenças não relacionadas ao refluxo, que podem gerar sintomas semelhantes à DRGE. Existem várias causas de refratariedade ao IBP, como uso inadequado da droga (falta de aderência do paciente à terapia com IBP, dosagem inadequada de IBP), refluxo ácido residual devido à supressão ácida inadequada, escape ácido noturno, refluxo "não-ácido", metabolismo rápido do IBP, esvaziamento gástrico lento e diagnóstico equivocado de DRGE. Este representa uma causa frequente de insucesso do tratamento clínico e neste caso, o problema não é o tratamento, mas sim o diagnóstico. As causas de diagnóstico equivocado da DRGE são pirose funcional, acalásia, megaesôfago, esofagite eosinofílica, outros tipos de esofagite e outras causas. O diagnóstico e o tratamento são específicos para cada uma dessas causas de refratariedade ao tratamento clínico com IBP.

Evolución clínica, funcional y radiológica de pacientes trasplantados pulmonares con síndrome de bronquiolitis obliterante y disfunción de injerto pulmonar restrictivo / Clinical, functional and radiological evolution of pulmonary transplant patients with bronchiolitis obliterans syndrome and restrictive graft dysfunction

Resumen La principal complicación a largo plazo en trasplantados de pulmón es la disfunción crónica de injerto identificado como bronquiolitis obliterante, existiendo un nuevo patrón denominado Disfunción de Injerto Restrictivo. Objetivo: Evaluar seguimiento espirométrico, radiológico y clínico entre pacientes con síndrome de bronquiolitis obliterante (SBO) y Disfunción de Injerto Restrictivo (DIR) post trasplante pulmonar. Metodología: Se revisaron registros clínicos de trasplantados pulmonares desde 1999 hasta 2017. Se efectuó seguimiento espirométrico e imágenes por tomografía de tórax y factores asociados: infección por Citomegalovirus(CMV), reflujo gastro-esofágico (RGE) y episodios de rechazo agudo. Se analizó sobrevida por Kaplan Meier. Resultados: De 88 pacientes trasplantados de pulmón, 40 desarrollaron disfunción crónica de injerto: 31 (80%) presentaron SBO y 9 (20%) tuvieron DIR. Edad promedio: 47 años en SBO y 46 años en DIR. Siendo fibrosis pulmonar la patología basal predominante en ambos. En SBO se consignaron 14 episodios de rechazo agudo (50%), infección por CMV en 18% y RGE activo en 26%. En la serie DIR hubo 5 episodios de rechazo agudo (62%), 13% de infección por CMV y 67% de RGE activo 6 (p = 0,02). En el seguimiento a 1-2-4-5 años el promedio del VEF1 en SBO fue: 67,3,65, 60 y 48% del valor predicho y en DIR fue 61, 65, 62 y 45% respectivamente. Las imágenes tomográficas en SBO mostraron: hiperinflación y en DIR: fibrosis pleuropulmonar superior. La sobrevida fue de 96,9 meses en SBO y 65,6 meses en DIR (p = 0,06). Conclusions: La disfunción restrictiva presentó menor sobrevida que SBO. RGE se asoció a rechazo restrictivo. La tomografía de tórax difiere en ambos tipos de rechazo crónico.

The main long-term complication in lung transplant patients is chronic graft dysfunction identified as bronchiolitis obliterans, and there is a new pattern called Restrictive Graft Dysfunction. Objective: To evaluate spirometric, radiological and clinical follow-up among patients with bronchiolitis obliterans syndrome (BOS) and Restrictive Allograft Syndrome (RAS) after lung transplantation. Methodology: Lung transplant recipients ' clinical records were reviewed from 1999 to 2017. We carried out a follow up of spirometry, chest tomography imaging and associated factors: cytomegalovirus (CMV) infection, gastroesophageal reflux (GER) and episodes of acute rejection. Survival was analyzed by Kaplan Meier. Results: Out of 88 lung transplant patients, 40 developed chronic graft dysfunction: 31 (80%) presented BOS and 9 (20%) had RAS. Mean age: 47 yr.o. in BOS and 46 yr. o. in RAS. Lung fibrosis was the primary pathology predominant in both conditions. In BOS were reported 14 episodes of acute rejection (50%), CMV infection in 18% and active GER in 26%. In RAS there were 5 episodes of acute rejection (62%), CMV infection in 13% and active GER in 67% (p = 0.02). VEF1 follow-up at 1-2-4-5 years averaged 67, 65, 60 and 8% of reference value in BOS and 61, 65, 62 and 45% in RAS respectively. CT scans showed hyperinflation in BOS and upper pleuropulmonary fibrosis in RAS. BOS survival time was 96.9 months versus 65.6 months in RAS (p = 0.06). Conclusiones: Restrictive dysfunction presented a lower survival rate than BOS. GER was associated with restrictive rejection. Chest tomography differs in both types of chronic rejection.

¿El reflujo gastroesofágico y la aspiración de contenido gástrico están implicados en la etiopatogenia y la progresión de la fibrosis pulmonar idiopática? / Does gastroesophageal reflux and gastric content aspiration have some role in the pathogenesis and progression of Idiopathic Pulmonary Fibrosis?

Resumen El reflujo gastroesofágico (RGE) y la aspiración oculta de contenido digestivo están probablemente implicados en la etiopatogenia y progresión de la fibrosis pulmonar idiopática (FPI). Los mecanismos patogénicos involucrados son la disminución de la distensibilidad pulmonar y el consiguiente aumento de la presión negativa intratorácica durante la inspiración, así como la disminución de los mecanismos de control de la motilidad esofágica o del tono del esfínter esofágico inferior. La prevalencia de RGE y anomalías de la motilidad esofágica están aumentadas en los pacientes con FPI comparado con la población general. Entre los pacientes con FPI, el 67-76% demostraron exposición anormal al contenido ácido en el esófago. Sin embargo, no hubo relación entre la gravedad del RGE y la gravedad de la FPI. Los estudios que han examinado el tratamiento antirreflujo en esta población han sido escasos. Incluso, algunos datos sugieren que el tratamiento antiácido puede ser perjudicial en algunos pacientes con esta condición. Después de analizar toda la evidencia relevante encontrada hasta la fecha, concluimos que no se puede establecer una relación causal entre el RGE, la aspiración del contenido gástrico y la patogénesis de la FPI. Además, existe escasa evidencia clínica que haya examinado el tratamiento antirreflujo en pacientes con fibrosis pulmonar idiopática.

ABSTRACT Gastroesophageal reflux (GERD) and hidden aspiration of gastric contents are probably involved in the pathogenesis and progression of idiopathic pulmonary fibrosis (IPF). The pathological mechanisms involved are decreased pulmonary distensibility and consequent increase of intrathoracic negative pressure during inspiration, as well as decreased control mechanisms of esophageal motility or lower esophageal sphincter. The prevalence of GERD and oesophageal dysmotility was higher in patients with IPF as compared with general population. Among patients with IPF, 67-76% demonstrated abnormal oesophageal acid exposure. However, no relationship was demonstrated between severity of GERD and severity of IPF. Data are scant on outcomes of antireflux treatment in patients with IPF. Actually, some data suggests that antacid treatment may be deleterious in some IPF patients. After analyzing all the relevant evidence found to date, a causal relationship between GERD, gastric content aspiration and IPF pathogenesis cannot be established. There is scant evidence examining antireflux treatment in idiopathic pulmonary fibrosis patients.

Neumopatía por aspiración (sindrome aspirativo / Aspiration pneumonia (aspiration syndrome)

Aspiration pulmonary disease is the condition in which there is a passage of gastric or oral content to the airways; the extent of aspiration is conditioned by the amount and frequency with which it occurs. The diagnostic approach of this pathology begins with an adequate clinical history with special emphasis on pathologies that generate poor swallowing mechanics such as neurological diseases, esophageal atresia and patients with a history of gastroesophageal reflux. The studies used for the diagnosis of this syndrome are chest X-ray, swallowing mechanics evaluation with barium, Ph-metry, scintigraphy with Tc99 for gastroesophageal reflux, delayed pulmonary scanning, endoscopic study of the digestive tract and bronchoscopy in search of lesions in the respiratory mucosa and bronchial lavage to detect lipid-laden alveolar macrophages which have been linked to the presence of aspiration syndromes in several publications

La neumopatía por aspiración es la condición en la que existe un paso de contenido gástrico a la vía aérea. La magnitud de la aspiración depende de la cantidad y la frecuencia con la que se presenta. El abordaje diagnóstico de esta patología se inicia con una historia clínica adecuada con especial énfasis en patologías que generen una mala mecánica de deglución como pueden ser enfermedades neurológicas, atresia esofágica y pacientes con antecedentes de reflujo gastroesofágico. Los estudios que se requieren para el diagnóstico de esta enfermedad constan de radiografía de tórax, estudio de deglución, Ph-metria, gamagrama para reflujo, estudio endoscópico de vía digestiva y broncoscopia en búsqueda de lesiones en la mucosa respiratoria y realización de lavado bronquial para macrófagos alveolares cargados de lípidos

Estridor persistente / Persistent stridor

Stridor is a musical, often high-pitched sound produced by a rapid, turbulent flow of air through a narrowed segment of the large airways. The cause of stridor can be located anywhere in the extrathoracic airway (nose, pharynx, larynx, and trachea) or the intrathoracic airway (tracheobronchial tree). Stridor may be acute (caused by inflammation/infection or foreign body inhalation) or chronic. It may be congenital or acquired. Various congenital and acquired disorders prevail in neonates, infants, children, and adolescents, and need to be distinguished. Medical history and age of the child, together with physical examination, often allow a presumptive diagnosis. Further tests may be necessary to establish a definite diagnosis, and flexible airway endoscopy is the diagnostic procedure of choice in most circumstances

Estridor es un sonido musical, de alta frecuencia, generado por el paso de un flujo de aire turbulento en zonas con calibre disminuido de la vía aérea de mayor tamaño.La causa del estridor puede estar localizado en cualquier lugar de la vía aérea extratorácica (nariz, faringe, laringe y tráquea) o la vía aérea intratorácica (árbol traqueobronquial). El estridor puede ser agudo (causado por inflamación/infección o aspiración de cuerpos extraños) o crónica. Puede ser congénita o adquirida. Varios trastornos congénitos y adquiridos prevalecen en neonatos, lactantes, niños y adolescentes, y tienen que ser distinguidos. La historia clínica, edad del niño y examen físico a menudo permiten un diagnóstico presuntivo. Puede requerirse mayor estudio para establecer un diagnóstico definitivo, y la endoscopia flexible de la vía aérea es el procedimiento diagnóstico de elección en la mayoría de las circunstancias

Terapia vocal breve e intensiva para paralisia unilateral de prega vocal / Intensive voice therapy for unilateral vocal fold paralysis

Introdução: A paralisia unilateral de prega vocal (PUPV) acarreta distúrbios vocais em graus variados que podem comprometer a fonação, deglutição e respiração, além de impactos na qualidade de vida. A terapia breve intensiva (TBI) é baseada nos princípios da neurobiologia, fisiologia do exercício, aprendizagem motora e psicoterapia. O programa consiste em múltiplas sessões com uma variedade de clínicos, incorporando múltiplas e simultâneas abordagens terapêuticas em um regime intensivo. O tratamento pode propiciar bons resultados funcional, além de aumentar o grau de adesão e reduzir a possibilidade de abandono. Não há dados de seus resultados na paralisia unilateral de prega vocal. Objetivo: Avaliar os efeitos da TBI em pacientes com paralisia unilateral de prega vocal; analisar os fatores preditivos da evolução do tratamento e a manutenção dos resultados no longo prazo. Metodologia: Estudo de coorte prospectivo e caráter descritivo. Pacientes diagnosticados com PUPV foram avaliados antes e após o programa de TBI e após 6 meses de seu término, por meio da avaliação laringológica, perceptiva auditiva, avaliação acústica, questionário IDV-10 (Índice de Desvantagem Vocal) e URICA ­ voz (Estágio de prontidão pra terapia). A TBI foi realizada individualmente em um total de 10 sessões com duração de 2 semanas. Resultados: Participaram do estudo 62 pacientes e finalizaram o programa de TBI 53 (85,5%). Os pacientes apresentaram redução da fenda glótica após a intervenção (81,1%) com melhora estatisticamente significante (p = 0,001) e manutenção dos resultados após 6 meses. Os parâmetros perceptivos (GRBASI) e as medidas acústicas tiveram melhora estatisticamente significante (p = 0,002) e manutenção dos resultados no longo prazo, com exceção da medida acústica de VTI, que apresentou discreta piora após 6 meses. A qualidade de vida relacionada à voz apresentou melhora progressiva no pós-imediato e após 6 meses (p = 0,001). A Doença do refluxo gastroesfágico que estava presente em 15 pacientes (24,2%) foi um fator preditivo para a não melhora vocal durante o programa de TBI. Profissionais da voz (p = 0,001) e estar no estágio de ação no questionário URICA ­ voz (p = 0,001) foram fatores associados significantemente à adesão ao programa de reabilitação. Conclusão: A TBI favorece melhora dos aspectos fisiológicos, perceptivos, acústicos e de qualidade de vida relacionada à voz de pacientes com PUPV. Ser profissional da voz e estar em estágio de prontidão para terapia, em ação, são fatores relacionados com a boa resposta ao programa. A presença da doença do refluxo gastroesofágico aumenta em 5 vezes a possibilidade de não melhora vocal

Introduction: Unilateral vocal fold paralysis (UVFP) leads to vocal disorders in different degrees that may compromise phonation, swallowing and breathing, as well as in quality of life. Intensive Voice Therapy (IVT) is based on the principles of neurobiology, physiology exercise, motor learning and psychotherapy. The program consists of multiple sessions with a variety of clinicians, incorporating multiple and simultaneous therapeutic approaches in an intensive way. The treatment can provide good functional results, besides increasing the degree of adhesion and reduce the possibility of abandon. Objective: To evaluate the effects of intensive voice therapy in patients with unilateral vocal fold paralysis, to define the factors associated with the evolution and to maintain the results in the long term. Method: Prospective cohort study and descriptive character. Patients diagnosed with UVFP were evaluated before, after finishing the program and after 6 months, evaluated with laryngological, auditory perceptual, acoustic, VHI-10 (Vocal Disadvantage Index) and URICA - (Therapy readiness stage). IVT was performed individually with a total of 10 sessions, lasting 2 weeks. Results: Sixty-two patients participated in the study and 53 (85.5%) completed the IVT program. The patients that presented reduction of the glottic cleft after the intervention was (81.1%) with statistically significant improvement (p = 0.001) and maintenance the results after 6 months. The perceptual parameters (GRBASI) and acoustic measures had statistically significant improvement after IVT (p = 0.002) and maintenance of the results in the long term, except for the VTI acoustic measurement, which presented a slight worsening after 6 months. The quality of life related to voice also showed progressive improvement (p = 0.001). Gastroesophageal reflux disease that was present in 15 patients (24.2%) was a predictive factor for non-vocal improvement during an IVT program. The factors for adherence to the program had a statistically significant relationship with being a voice professional (p = 0.001) and being at the stage of action on the URICA - voice questionnaire (p = 0.001). Conclusion: The IVT program improves the perceptive, physiological, acoustic and quality of life related to the voice of patients with UVFP reaching satisfactory results. Voice professional and readiness stage in action are factors related to the good response to the program. The presence of gastroesophageal reflux disease increases 5 times the possibility of no vocal improvement

Fundoplication conversion in roux-en-y gastric bypass for control of obesity and gastroesophageal reflux: systematic review / Conversão de fundoplicatura em bypass gástrico em y-de-roux para controle da obesidade e do refluxo gastroesofágico: revisão sistemática

ABSTRACT Introduction : Obesity is related with higher incidence of gastroesophageal reflux disease. Antireflux surgery has inadequate results when associated with obesity, due to migration and/or subsequent disruption of antireflux wrap. Gastric bypass, meanwhile, provides good control of gastroesophageal reflux. Objective: To evaluate the technical difficulty in performing gastric bypass in patients previously submitted to antireflux surgery, and its effectiveness in controlling gastroesophageal reflux. Methods: Literature review was conducted between July to October 2016 in Medline database, using the following search strategy: ("Gastric bypass" OR "Roux-en-Y") AND ("Fundoplication" OR "Nissen ') AND ("Reoperation" OR "Reoperative" OR "Revisional" OR "Revision" OR "Complications"). Results: Were initially classified 102 articles; from them at the end only six were selected by exclusion criteria. A total of 121 patients were included, 68 women. The mean preoperative body mass index was 37.17 kg/m² and age of 52.60 years. Laparoscopic Nissen fundoplication was the main prior antireflux surgery (70.58%). The most common findings on esophagogastroduodenoscopy were esophagitis (n=7) and Barrett's esophagus (n=6); the most common early complication was gastric perforation (n=7), and most common late complication was stricture of gastrojejunostomy (n=9). Laparoscopic gastric bypass was performed in 99 patients, with an average time of 331 min. Most patients had complete remission of symptoms and efficient excess weight loss. Conclusion: Although technically more difficult, with higher incidence of complications, gastric bypass is a safe and effective option for controlling gastroesophageal reflux in obese patients previously submitted to antireflux surgery, with the added benefit of excess weight loss.

RESUMO Introdução: Obesidade está relacionada à maior incidência de doença do refluxo gastroesofágico. Cirurgia antirrefluxo apresenta resultados inadequados quando associada à obesidade, devido à migração e/ou ruptura posterior da válvula antirrefluxo. Bypass gástrico enquanto isso determina bom controle de refluxo gastroesofágico. Objetivo: Avaliar a dificuldade técnica na realização de bypass gástrico em pacientes previamente submetidos à cirurgia antirrefluxo, e sua eficácia no controle do refluxo gastroesofágico. Método: Revisão de literatura foi realizada entre os meses de julho a outubro de 2016, na base de dados Medline, com a seguinte estratégia de busca: ("Gastric Bypass" OR "Roux-en-Y") AND ("Fundoplication" OR "Nissen") AND ("Reoperation" OR "Reoperative" OR "Revisional" OR "Revision" OR "Complications"). Resultados: Foram inicialmente classificados 102 artigos selecionando-se, por critérios de exclusão, apenas seis ao final. Foram incluídos 121 pacientes, sendo 68 mulheres. A média de índice de massa corporal pré-operatório foi 37,17 kg/m² e idade de 52,60 anos. Fundoplicatura de Nissen laparoscópica foi a principal operação antirrefluxo prévia (70,58%). Os achados mais comuns na endoscopia digestiva alta foram esofagite (n=7) e esôfago de Barrett (n=6); a complicação precoce mais comum foi perfuração gástrica (n=7), e tardia, estenose de anastomose gastrojejunal (n=9). Bypass laparoscópico foi realizado em 99 pacientes, com tempo médio de 331 min. A grande maioria dos pacientes apresentou completa remissão dos sintomas e perda eficiente do excesso de peso. Conclusão: Apesar de tecnicamente mais difícil, com maior incidência de complicações, o bypass gástrico é opção segura e efetiva no controle do refluxo gastroesofágico em pacientes obesos previamente submetidos à operação antirrefluxo, com a vantagem adicional da perda do excesso de peso.

Baixa prevalência de esôfago de Barrett em área de risco para câncer esofágico no Sul do Brasil / Low prevalence of barrett's esophagus in a risk area for esophageal cancer in south of brazil

ABSTRACT BACKGROUND: Barrett's esophagus a complication of gastroesophageal reflux disease (GERD) is a precursor of esophageal adenocarcinoma. The incidence of esophageal adenocarcinoma has been increasing in most Western countries. Rio Grande do Sul (RS), the Southernmost state of Brazil has the highest rates of esophageal cancer with low prevalence of esophageal adenocarcinoma. OBJECTIVE: To investigate the prevalence of Barrett's esophagus among patients underwent to upper gastrointestinal endoscopy in the last 5 years. METHODS: The records of patients underwent upper gastrointestinal endoscopy between 2011 and 2015 were analyzed. Demographic data, GERD symptoms, endoscopic findings, extension and histological diagnosis of columnar epithelia of the esophagus were recorded. Significance among the variables was accessed by chi-square test and Fisher's exact test with 95% CI. RESULTS: A total of 5996 patients underwent to upper gastrointestinal endoscopy in the period were included. A total of 1769 (30%) patients with GERD symptoms or esophagitis and 107 (1.8%) with columnar lined esophagus were identified. Except for eight patients, the others with columnar lined esophagus had GERD symptoms or esophagitis. Barrett's esophagus defined by the presence of intestinal metaplasia occurred in 47 patients; 20 (43%) with segments over 3 cm and 27 (57%) with segments shorter than 3 cm. The global prevalence of Barrett's esophagus was 0.7% and in GERD patients 2.7%. The odds ratio for the occurrence of columnar lined esophagus in patients with GERD was 30 (95%CI=15.37-63.34). The odds ratio for the presence of intestinal metaplasia in long segments was 8 (95%CI=2.83-23.21). CONCLUSION: GERD patients had a risk 30-folds greater to present columnar lined esophagus than patients without GERD symptoms. Long segments of columnar lined esophagus, had a risk eight-folds higher to have Barrett's esophagus than short segments. Barrett's esophagus overall prevalence was 0.7%. In GERD patients, the prevalence was 2.7%. Long Barrett's esophagus represented globally 0.3% and 1.1% in GERD patients.

RESUMO CONTEXTO: Esôfago de Barrett, complicação da doença do refluxo gastroesofágico (DRGE), é lesão precursora do adenocarcinoma esofágico. O adenocarcinoma esofágico apresenta incidência crescente principalmente no ocidente. O estado do Rio Grande do Sul apresenta as taxas mais altas de câncer esofágico no Brasil, porém com baixa prevalência de adenocarcinoma. OBJETIVO: Investigar a prevalência de esôfago de Barrett em pacientes submetidos a endoscopia digestiva alta nos últimos 5 anos. MÉTODOS: Revisão de prontuários dos pacientes submetidos a endoscopia digestiva alta entre 2011 e 2015. Registrados dados demográficos, sintomas de DRGE, achados endoscópicos, extensão e diagnóstico histológico de epitelização colunar do esôfago. A significância entre as variáveis foi acessada pelos testes do qui-quadrado e exato de Fisher com IC95%. RESULTADOS: Foram incluídos 5996 pacientes. Identificamos 1769 (30%) com sintomas de DRGE ou esofagite e 107 (1,8%) com epitelização colunar. À exceção de oito pacientes com epitelização colunar, os demais apresentavam sintomas de DRGE ou esofagite. Esôfago de Barrett definido pela presença de metaplasia intestinal ocorreu em 47 pacientes; 20 (43%) com segmentos acima de 3 cm e em 27 (57%) com segmentos menores. A prevalência global de esôfago de Barrett foi 0,7% e em pacientes com DRGE foi 2,7%. A razão de chances para a ocorrência de epitelização colunar em pacientes com DRGE foi 30 (IC95%=15,37-63,34) e para a ocorrência de metaplasia intestinal em segmentos longos foi 8 (IC95%=2,83-23,21). CONCLUSÃO: Pacientes com DRGE apresentaram risco 30 vezes maior que pacientes sem DRGE para a ocorrência de epitelização colunar. O risco de ocorrência de esôfago de Barrett em segmentos longos foi oito vezes maior. A prevalência global de esôfago de Barrett foi 0,7%. Em pacientes com DRGE a prevalência foi 2,7%. Segmentos longos de esôfago de Barrett representaram globalmente 0,3% e em pacientes com DRGE 1,1%.